Gemtaz Infusmart 1.6 Gm Injection

Description

Gemtaz Infusmart 1.6gm Injection is a critical therapeutic agent used in the management of certain types of cancer. Its active ingredient is Gemcitabine, a nucleoside analog that works by interfering with DNA synthesis in rapidly dividing cancer cells. By inhibiting DNA replication and repair, Gemcitabine ultimately leads to the death of these malignant cells. This injection is primarily indicated for the treatment of various cancers, including pancreatic cancer, non-small cell lung cancer, and breast cancer, often in combination with other chemotherapy agents. The dosage and administration of Gemtaz Infusmart 1.6gm Injection are determined by the treating physician based on the specific cancer type, stage, and the patient’s overall health. Common side effects may include fatigue, nausea, vomiting, fever, and a decrease in blood cell counts (white blood cells, red blood cells, and platelets). Patients may experience flu-like symptoms. It is crucial to report any adverse reactions to a healthcare professional immediately. Gemtaz Infusmart 1.6gm Injection should be stored at room temperature, protected from light, and should not be frozen. It is administered intravenously by a qualified healthcare provider.